Citations 1
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
Zinzani, Pier Luigi , Salles, Gilles , Moskowitz, Alison J. , Santoro, Armando , Mehta, Amitkumar , Barr, Paul M. , Mehta–Shah, Neha , Ansell, Stephen M. , Brody, Joshua , Domingo‐Doménech, Eva , Johnson, Nathalie A. , Cunningham, David , Ferrari, Silvia , Lisano, Julie , Krajewski, Jennifer , Wen, Rachael, Akyol, Alev, Crowe, Russell, Brody, Joshua D , Domingo-Domenech, Eva , Cunningham, David , Ferrari, Silvia , Savage, Kerry J , Barr, Paul M , Zinzani, Pier Luigi , Salles, Gilles A , Santoro, Armando , Mehta, Amitkumar , Collins, Graham P. , Savage, Kerry J.
Blood Advances | March 26, 2024 | Volume: 8 | Issue: 10 | Pages: 2400-2404
